Market Overview:
Capillaria infection (Capillariasis), is a parasitic disease in humans caused by two different species of capillarids, Capillaria hepatica and Capillaria philippinensis. The capillariasis is of two forms including intestinal capillariasis and hepatic capillariasis. Human infection is caused by the intake of food or water contaminated with infective eggs. C. philippinensis is identified by the presence of eggs, larvae, and/or adult worms in feces or intestinal biopsies. The most common stage seen in feces is unembryonated eggs. In severe infestations, feces may contain embryonated eggs, larvae, and even adult worms.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Medix Laboratoires (Belgium), Johnson & Johnson (United States), Pan Laboratories (United States), Cadila Healthcare (India), Andre Laboratories Pvt Ltd (India), Cipla Limited (India), EMCEE Pharmaceuticals (P) Ltd. (India), GlaxoSmithKline Pharmaceuticals Ltd (India), Esquire Drug House (India) and Wings Pharmaceuticals Pvt. Ltd. ((India) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region or narrow down segments in the final scope subject to feasibility |
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics of major and emerging geographies across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Key Players of Capillaria Infection Market Study:
Medix Laboratoires (Belgium), Johnson & Johnson (United States), Pan Laboratories (United States), Cadila Healthcare (India), Andre Laboratories Pvt Ltd (India), Cipla Limited (India), EMCEE Pharmaceuticals (P) Ltd. (India), GlaxoSmithKline Pharmaceuticals Ltd (India), Esquire Drug House (India) and Wings Pharmaceuticals Pvt. Ltd. ((India)
Capillaria Infection Market Segment Analysis
Scope | Sub-Segments |
---|
Type | Intestinal Capillariasis and Hepatic Capillariasis |
Drugs | Mebendazole,Albendazole,Steroids |
End-users | Hospitals,Clinics,Others |
Distribution Channel | Hospital Pharmacy,Retail Pharmacy,Online |
Diagnosis | Stool Test,Intestinal Biopsy |
Symtoms | Weight Loss,Watery Diarrhea,Edema,Abdominal Pain,Others |
Influencing Trend:
Technological Advancements in Medical Science and Increased Number of Online Pharmacies
Market Growth Drivers:
Increasing Prevalence of Capillaria Infection and Increased Number of Diagnostic Centres
Challenges:
Stringent Government Rules and Regulations
Restraints:
Less Awareness among People
Opportunities:
Growing Healthcare Industry Worldwide and Increasing Research and Development Activities
Some of the other players that are also part of study are Yash Pharmaceuticals Ltd (India) and Raptakos Brett & Co. Ltd. (India). The Global Capillaria Infection market is gaining huge competition due to involvement of Indian companies that constantly invest in research & development to meet market expectation with new innovation.
In 2020, Johnson & Johnson announced an acquisition deal worth a USD 6.5 billion pharmaceutical involving biotechnology company Momenta Pharmaceuticals, Inc.
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Capillaria Infection market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Capillaria Infection market.
Identification of total players or companies operating in the global market which is further concentrated to fewer or most impacting players which are considered under the report’s scope. In order to make a priority list sorting is done based on revenue generated based on the latest reporting with the help of paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Capillaria Infection Treatment Providers, Distributors, Research Professionals, Emerging Companies and End-users.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.